FDA DELAYS FINAL REVIEW OF SUBLOCADE LABEL CHANGES
FOLLOWING ACCEPTANCE OF PROPOSED LABEL FOR SUBLOCADE, THERE WERE NO OUTSTANDING ITEMS TO ADDRESS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.